WNT2B Deficiency Causes Enhanced Susceptibility to Colitis Due to Increased Inflammatory Cytokine Production
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Apr 2024 · 1 min read
In brief
In brief
WNT2B deficiency increases susceptibility to colitis through dysregulated inflammatory cytokine production rather than epithelial defects. Mouse models and human organoids demonstrate elevated CXCR4 and IL6 expression, with enhanced neutrophil infiltration driving severe inflammatory injury in the colon.
Written by the GCMD Library team from the article.
Statements in this article
Humans with WNT2B deficiency have severe intestinal disease, including significant inflammatory injury.
Mice with WNT2B deficiency had normal baseline intestinal histology in both small intestine and colon.
WNT2B-deficient mice showed enhanced susceptibility to dextran sodium sulfate (DSS) colitis due to an increased early injury response.
Intestinal stem cell markers were decreased in WNT2B-deficient mice, but epithelial proliferation was similar to control subjects.
WNT2B knockout mice showed an enhanced inflammatory signature after DSS treatment.
WNT2B knockout colon tissue had increased levels of CXCR4 and IL6.
Human WNT2B-deficient intestinal organoids had increased levels of CXCR4 and IL6.
Biopsy tissue from humans with WNT2B deficiency showed increased neutrophils.
WNT2B is important for regulation of inflammation in the intestine.
Absence of WNT2B leads to increased expression of inflammatory cytokines and increased susceptibility to gastrointestinal inflammation, particularly in the colon.
